A Phase 2 Study of RTB101 as COVID-19 Post-Exposure Prophylaxis in Older Adults

NCT04584710 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Covid19

Interventions

DRUG: RTB101
DRUG: Placebo

Sponsor

Restorbio Inc.

Collaborators

[object Object]